Congressional Trader
Live

BBIO congressional trades

7 matched disclosures

Track congressional trades for BBIO
Tracked disclosures
7
Lawmakers
1
Buy / sell
7 / 0
Avg post-trade move
-3.8%
Latest filing 2026-06-08

BBIO congressional trades snapshot

This page summarizes public STOCK Act disclosures involving BBIO. It is useful for seeing which lawmakers reported BBIO transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Jun 8, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the BBIO congressional trade page shows

Congressional Trader tracks 7 public STOCK Act disclosures for BBIOacross 1 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent BBIO filing shown here was filed on Jun 8, 2026 by Gilbert Ray Cisneros as a purchase. Related lawmakers include Gilbert Ray Cisneros.

Top lawmakers for BBIO

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
No committee data
Filed Jun 8, 2026
Delay 28 days
View filing
BBIONotable
BridgeBio Pharma, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 8, 2026
Delay 9 days
View filing
BBIONotable
BridgeBio Pharma, Inc. - Common
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Apr 7, 2026
Delay 19 days
View filing
BBIONotable
BridgeBio Pharma, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Apr 7, 2026
Delay 20 days
View filing
BBIONotable
BridgeBio Pharma, Inc. - Common
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Apr 7, 2026
Delay 35 days
View filing
BBIONotable
BridgeBio Pharma, Inc. - Common
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Oct 10, 2025
Delay 18 days
View filing
BBIONotable
BridgeBio Pharma, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Sep 12, 2025
Delay 35 days
View filing
BBIONotable
BridgeBio Pharma, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded BBIO?

Recent BBIO disclosures include Gilbert Ray Cisneros.

What is the buy/sell mix for BBIO?

The visible sample currently shows 7 purchases and 0 sales or partial sales.

Should I trade based on BBIO disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.